Dodge & Cox — NBIX Trade History
Quarter-by-quarter changes in the Neurocrine Biosciences, Inc. position · CUSIP 64125C109
Currently held · 3 YearsFirst seen: 2023 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Add | 5,584,707 | 123,670 | +2.3% | $941.2M | 0.49% |
| 2026 Q1 | 2026-05-14 | Reduce | 5,461,037 | -47,005 | -0.9% | $719.4M | 0.40% |
| 2025 Q4 | 2026-02-13 | Reduce | 5,508,042 | -48,576 | -0.9% | $781.2M | 0.42% |
| 2025 Q3 | 2025-11-13 | Reduce | 5,556,618 | -10,196 | -0.2% | $780.0M | 0.42% |
| 2025 Q2 | 2025-08-13 | Add | 5,566,814 | 32,190 | +0.6% | $699.7M | 0.39% |
| 2025 Q1 | 2025-05-14 | Add | 5,534,624 | 2,518,199 | +83.5% | $612.1M | 0.35% |
| 2024 Q4 | 2025-02-13 | Add | 3,016,425 | 1,728,605 | +134.2% | $411.7M | 0.24% |
| 2024 Q3 | 2024-11-13 | Add | 1,287,820 | 7,000 | +0.5% | $148.4M | 0.08% |
| 2024 Q2 | 2024-08-13 | Add | 1,280,820 | 15,576 | +1.2% | $176.3M | 0.11% |
| 2024 Q1 | 2024-05-14 | Add | 1,265,244 | 5,500 | +0.4% | $174.5M | 0.10% |
| 2023 Q4 | 2024-02-22 | Add | 1,259,744 | 1,046,142 | +489.8% | $166.0M | 0.10% |
| 2023 Q3 | 2023-11-14 | New | 213,602 | 213,602 | — | $24.0M | 0.02% |
| 2023 Q2 | 2023-08-14 | — | — | — | — | — | — |
| 2023 Q1 | 2023-05-12 | — | — | — | — | — | — |
| 2022 Q4 | 2023-02-14 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-10 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-12 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-13 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-14 | — | — | — | — | — | — |
| 2021 Q3 | 2021-11-15 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-13 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-14 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-11 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-13 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-13 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-21 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-14 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-13 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-11 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-12 | — | — | — | — | — | — |
| 2016 Q4 | 2017-03-20 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-14 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.